554
Views
48
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Pattern of spread and prognosis in lower limb-onset ALS

, , , , , & show all
Pages 369-373 | Received 20 Sep 2009, Accepted 15 Oct 2009, Published online: 10 Dec 2009

References

  • Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, . Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
  • Turner MR, Parton MJ, Shaw CE, Leigh PN, Al Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the Kings' database 1990–2002. J Neurol Neurosurg Psychiatry. 2003;74:995–7.
  • Hu MT, Ellis CM, Al Chalabi A, Leigh PN, Shaw CE. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1998;65:950–1.
  • Cappellari A, Ciammola A, Silani V. The pseudopolyneuritic form of amyotrophic lateral sclerosis (Patrikios' disease). Electromyogr Clin Neurophysiol. 2008;48:75–81.
  • Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, . Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72:1087–94.
  • Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68:1571–5.
  • Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss post mortem. Neurology. 2007;68:1576–82.
  • Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805–11.
  • Brooks BR, Sanjak M, Belden D, Juhazs-Poscine K, Waclawik A, Brown RH Jr, . Natural history of amyotrophic lateral sclerosis: impairment, disability, handicap. Amyotroph Lateral Scler. London: Martin Dunitz; 2000: 31–58.
  • Wohlfart G. Collateral regeneration in partially denervated muscles. Neurology. 1958;8:175–80.
  • Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, . The natural history of primary lateral sclerosis. Neurology. 2006;66:647–53.
  • Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, . Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
  • Ince PG, Evans J, Knopp M, Forster G, Hamdalla HH, Wharton SB, . Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003;60:1252–8.
  • Gowers WR. Diseases Of The Nervous System. Philadelphia: P. Blakiston, Son & Co.; 1893. 483.
  • Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707–19.
  • Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:15–21.
  • Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, . Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [(11)C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15:601–9.
  • Andersen PM, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keranen ML, . Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala Cu/Zn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain. 1996;119:1153–72.
  • Weber M, Eisen A, Stewart HG, Andersen PM. Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A Cu/Zn-superoxide dismutase mutation. Brain. 2000;123:1505–15.
  • Turner MR, Osei-Lah AD, Hammers A, Al Chalabi A, Shaw CE, Andersen PM, . Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. J Neurol NeurosurgPsychiatry. 2005;76:1279–85.
  • Turner MR, Hammers A, Al Chalabi A, Shaw CE, Andersen PM, Brooks DJ, . Distinct cerebral lesions in sporadic and ‘D90A’ SOD1 ALS: studies with [11C]flumazenil PET. Brain. 2005;128:1323–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.